Publisher： Adis International
ISSN： 1172-0360
Source： Drugs & Therapy Perspectives, Vol.27, Iss.8, 2011-08, pp. : 24-26
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
A recent systematic review and meta-analysis assessed the physical performance-enhancing effects of β2-adrenergic receptor agonists (β2-agonists) relative to placebo in randomized controlled trials in healthy participants. Inhaled β2-agonists (salbutamol [albuterol], formoterol, salmeterol and terbutaline) did not display any significant effects on endurance, strength or sprint performance. Some evidence indicates that systemic β2-agonists may have a positive effect on anaerobic capacity and strength, but the evidence base is weak and pertains only to the use of salbutamol.
Related content
Alpha2-Adrenergic Receptor Agonists as Analgesics
Current Topics in Medicinal Chemistry, Vol. 1, Iss. 3, 2001-08 ,pp. :
Access to resources
Recommend
2-Adrenergic agonists as analgesic agents
By Boyd R.E.
Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 11, 2000-11 ,pp. :
Neuroprotection by Alpha 2-Adrenergic Agonists in Cerebral Ischemia
Current Neuropharmacology, Vol. 3, Iss. 4, 2005-01 ,pp. :
By Vásquez J. Romero-Vecchione E. Davoli M.A. Lezama E.
Pharmacy and Pharmacology Communications, Vol. 5, Iss. 8, 1999-08 ,pp. :
Respiratory Effects of &bgr;-Adrenergic Receptor Blockers
Current Medicinal Chemistry, Vol. 14, Iss. 10, 2007-04 ,pp. :